GLASSIA^® [Alpha1-Proteinase Inhibitor (Human)] 1.0g / 50mL vial. Each single-use vial is labeled with the total Alpha1-Proteinase Inhibitor (Alpha1-PI) functional activity in mg. This vial size contains not less than 800 mg active Alpha1-PI. GLASSIA^® is packaged with a sterile 5-micron filter needle.

1501-2000 Activity Units; Including One bottle 10 mL dried Antihemophilic Factor (Human); 10 mL Sterile Water for Injection, USP; one double-ended needle; one filter needle; one physician insert.

220-400 Activity Units; Including One bottle 10 mL dried Antihemophilic Factor (Human); 10 mL Sterile Water for Injection, USP; one double-ended needle; one filter needle; one physician insert.

401-800 Activity Units; Including One bottle 10 mL dried Antihemophilic Factor (Human); 10 mL Sterile Water for Injection, USP; one double-ended needle; one filter needle; one physician insert.

801-1500 Activity Units; Including One bottle 10 mL dried Antihemophilic Factor (Human); 10 mL Sterile Water for Injection, USP; one double-ended needle; one filter needle; one physician insert.

Subcutaneous (SC) set with low flow resistance 24 G, 90° bent needle, winged hub, 24” tubing, transparent dressing with tape, and 0.9 ml priming volume. Refer to drug manufacturer’s package insert for dosing instructions.

Subcutaneous (SC) set with low flow resistance 24 G, 90° bent needle, winged hub, 24” tubing, transparent dressing with tape, and 0.9 ml priming volume. Refer to drug manufacturer’s package insert for dosing instructions.

Subcutaneous (SC) set with low flow resistance 24 G, 90° bent needle, winged hub, 24” tubing, transparent dressing with tape, and 0.9 ml priming volume. Refer to drug manufacturer’s package insert for dosing instructions.

Dual vial unit containing vial with 10 g of Immune Globulin Infusion 10% (Human) (100 mg/mL protein) and vial with 800 units of Recombinant Human Hyaluronidase (160 U/mL), for subcutaneous administration; physician/patient inserts

Dual vial unit containing vial with 2.5 g of Immune Globulin Infusion 10% (Human) (100 mg/mL protein) and vial with 200 units of Recombinant Human Hyaluronidase (160 U/mL), for subcutaneous administration; physician/patient inserts

Dual vial unit containing vial with 20 g of Immune Globulin Infusion 10% (Human) (100 mg/mL protein) and vial with 1600 units of Recombinant Human Hyaluronidase (160 U/mL), for subcutaneous administration; physician/patient inserts

Dual vial unit containing vial with 30 g of Immune Globulin Infusion 10% (Human) (100 mg/mL protein) and vial with 2400 units of Recombinant Human Hyaluronidase (160 U/mL), for subcutaneous administration; physician/patient inserts

Dual vial unit containing vial with 5 g of Immune Globulin Infusion 10% (Human) (100 mg/mL protein) and vial with 400 units of Recombinant Human Hyaluronidase (160 U/mL), for subcutaneous administration; physician/patient inserts